57/100B251.575
USD
1.06
(0.42%)
Market Open
Last updated: · Delayed 15 min
Fair value393.61Plus-36%295Price 251.58492
Q4 FY2026 · Earnings report
EPS estimate 2.81Revenue estimate 2.61B
Q4 FY2026 · Earnings report
EPS estimate 2.81Revenue estimate 2.61B
Biogen price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Biogen's P/S ratio is 3.61: its market cap of 37.19B USD over revenue of 10.30B USD in the last twelve months.
- Today
- 3.61
- Average, 5 years
- 3.04
- Low, 5 years
- 1.71
- High, 5 years
- 4.55
P/S ratio = market cap ÷ revenue (last 12 months) = 37.19B ÷ 10.30B = 3.61
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 3.61 | 37.19B | 10.30B | |
| FY2025 | 31 Dec 2025 | 2.61 | 25.82B | 9.89B |
| FY2024 | 31 Dec 2024 | 2.30 | 22.28B | 9.68B |
| FY2023 | 31 Dec 2023 | 3.81 | 37.44B | 9.84B |
| FY2022 | 31 Dec 2022 | 3.96 | 40.24B | 10.17B |
| FY2021 | 31 Dec 2021 | 3.26 | 35.77B | 10.98B |
| FY2020 | 31 Dec 2020 | 2.93 | 39.40B | 13.44B |
| FY2019 | 31 Dec 2019 | 3.86 | 55.52B | 14.38B |
| FY2018 | 31 Dec 2018 | 4.58 | 61.66B | 13.45B |
| FY2017 | 31 Dec 2017 | 5.52 | 67.73B | 12.27B |
| FY2016 | 31 Dec 2016 | 5.41 | 61.93B | 11.45B |
| FY2015 | 31 Dec 2015 | 6.57 | 70.67B | 10.76B |
| FY2014 | 31 Dec 2014 | 8.27 | 80.23B | 9.70B |
| FY2013 | 31 Dec 2013 | 9.55 | 66.24B | 6.93B |
| FY2012 | 31 Dec 2012 | 6.32 | 34.83B | 5.51B |
| FY2011 | 31 Dec 2011 | 5.28 | 26.68B | 5.05B |
| FY2010 | 31 Dec 2010 | 3.59 | 16.92B | 4.72B |
| FY2009 | 31 Dec 2009 | 3.51 | 15.37B | 4.38B |
| FY2008 | 31 Dec 2008 | 3.40 | 13.92B | 4.10B |
| FY2007 | 31 Dec 2007 | 5.67 | 17.98B | 3.17B |
| FY2006 | 31 Dec 2006 | 6.21 | 16.65B | 2.68B |
| FY2005 | 31 Dec 2005 | 8.87 | 15.20B | 1.71B |
| FY2004 | 31 Dec 2004 | 13.98 | 22.31B | 1.60B |
| FY2003 | 31 Dec 2003 | 65.80 | 12.25B | 186.13M |
| FY2002 | 31 Dec 2002 | 32.00 | 12.94B | 404.22M |
| FY2001 | 31 Dec 2001 | 25.79 | 26.88B | 1.04B |
| FY2000 | 31 Dec 2000 | 30.46 | 28.20B | 925.67M |
| FY1999 | 31 Dec 1999 | 18.54 | 14.73B | 794.44M |
| FY1998 | 31 Dec 1998 | 12.43 | 6.93B | 557.59M |
| FY1997 | 31 Dec 1997 | 11.59 | 5.03B | 434.04M |
| FY1996 | 31 Dec 1996 | 12.14 | 3.36B | 277.09M |
| FY1995 | 31 Dec 1995 | 15.10 | 2.29B | 151.69M |
| FY1994 | 31 Dec 1994 | 1.85 | 289.00M | 156.34M |
| FY1993 | 31 Dec 1993 | 5.25 | 716.54M | 136.40M |
| FY1992 | 31 Dec 1992 | 9.68 | 1.20B | 123.70M |
| FY1991 | 31 Dec 1991 | 23.82 | 1.46B | 61.40M |
| FY1990 | 31 Dec 1990 | 33.68 | 1.69B | 50.10M |
| FY1989 | 31 Dec 1989 | 42.76 | 1.22B | 28.50M |
| FY1988 | 31 Dec 1988 | 36.41 | 750.00M | 20.60M |
| FY1987 | 31 Dec 1987 | 189.51 | 1.63B | 8.60M |
| FY1986 | 31 Dec 1986 | 229.49 | 1.47B | 6.40M |
| FY1985 | 31 Dec 1985 | 91.22 | 1.38B | 15.10M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 3.24 | 33.39B | 10.30B |
| Q2 FY2026 | 30 Jun 2026 | 3.18 | 31.91B | 10.03B |
| Q1 FY2026 | 31 Mar 2026 | 2.72 | 26.99B | 9.94B |
| Q4 FY2025 | 31 Dec 2025 | 2.61 | 25.82B | 9.89B |
| Q3 FY2025 | 30 Sept 2025 | 2.04 | 20.54B | 10.07B |
| Q2 FY2025 | 30 Jun 2025 | 1.83 | 18.32B | 10.00B |
| Q1 FY2025 | 31 Mar 2025 | 2.03 | 19.96B | 9.82B |
| Q4 FY2024 | 31 Dec 2024 | 2.30 | 22.28B | 9.68B |
| Q3 FY2024 | 30 Sept 2024 | 2.94 | 28.24B | 9.61B |
| Q2 FY2024 | 30 Jun 2024 | 3.49 | 33.75B | 9.67B |
| Q1 FY2024 | 31 Mar 2024 | 3.23 | 31.19B | 9.66B |
| Q4 FY2023 | 31 Dec 2023 | 3.81 | 37.50B | 9.84B |
| Q3 FY2023 | 30 Sept 2023 | 3.72 | 37.22B | 9.99B |
| Q2 FY2023 | 30 Jun 2023 | 4.13 | 41.22B | 9.97B |
| Q1 FY2023 | 31 Mar 2023 | 3.97 | 40.15B | 10.10B |
| Q4 FY2022 | 31 Dec 2022 | 3.92 | 39.90B | 10.17B |
| Q3 FY2022 | 30 Sept 2022 | 3.72 | 38.55B | 10.36B |
| Q2 FY2022 | 30 Jun 2022 | 2.80 | 29.75B | 10.63B |
| Q1 FY2022 | 31 Mar 2022 | 2.86 | 30.98B | 10.82B |
| Q4 FY2021 | 31 Dec 2021 | 3.21 | 35.24B | 10.98B |
| Q3 FY2021 | 30 Sept 2021 | 3.77 | 41.88B | 11.10B |
| Q2 FY2021 | 30 Jun 2021 | 4.43 | 51.84B | 11.70B |
| Q1 FY2021 | 31 Mar 2021 | 3.37 | 42.49B | 12.60B |
| Q4 FY2020 | 31 Dec 2020 | 2.80 | 37.63B | 13.44B |
| Q3 FY2020 | 30 Sept 2020 | 3.12 | 44.51B | 14.26B |
| Q2 FY2020 | 30 Jun 2020 | 2.97 | 42.97B | 14.49B |
| Q1 FY2020 | 31 Mar 2020 | 3.79 | 54.67B | 14.42B |
| Q4 FY2019 | 31 Dec 2019 | 3.67 | 52.76B | 14.38B |
| Q3 FY2019 | 30 Sept 2019 | 3.01 | 42.84B | 14.23B |
| Q2 FY2019 | 30 Jun 2019 | 3.18 | 44.81B | 14.07B |
| Q1 FY2019 | 31 Mar 2019 | 3.31 | 45.71B | 13.81B |
| Q4 FY2018 | 31 Dec 2018 | 4.47 | 60.12B | 13.45B |
| Q3 FY2018 | 30 Sept 2018 | 5.37 | 71.01B | 13.23B |
| Q2 FY2018 | 30 Jun 2018 | 4.67 | 60.11B | 12.87B |
| Q1 FY2018 | 31 Mar 2018 | 4.60 | 57.89B | 12.59B |
| Q4 FY2017 | 31 Dec 2017 | 5.49 | 67.38B | 12.27B |
| Q3 FY2017 | 30 Sept 2017 | 5.59 | 66.19B | 11.84B |
| Q2 FY2017 | 30 Jun 2017 | 4.91 | 57.50B | 11.72B |
| Q1 FY2017 | 31 Mar 2017 | 5.11 | 58.95B | 11.53B |
| Q4 FY2016 | 31 Dec 2016 | 5.37 | 61.42B | 11.45B |
| Q3 FY2016 | 30 Sept 2016 | 6.00 | 68.52B | 11.42B |
| Q2 FY2016 | 30 Jun 2016 | 4.71 | 52.98B | 11.24B |
| Q1 FY2016 | 31 Mar 2016 | 5.21 | 56.98B | 10.94B |
| Q4 FY2015 | 31 Dec 2015 | 6.27 | 67.52B | 10.76B |
| Q3 FY2015 | 30 Sept 2015 | 6.41 | 67.76B | 10.57B |
| Q2 FY2015 | 30 Jun 2015 | 9.23 | 95.05B | 10.30B |
| Q1 FY2015 | 31 Mar 2015 | 9.80 | 99.22B | 10.13B |
| Q4 FY2014 | 31 Dec 2014 | 8.24 | 79.93B | 9.70B |
| Q3 FY2014 | 30 Sept 2014 | 8.66 | 78.14B | 9.03B |
| Q2 FY2014 | 30 Jun 2014 | 8.94 | 74.62B | 8.34B |
| Q1 FY2014 | 31 Mar 2014 | 9.47 | 72.43B | 7.65B |
| Q4 FY2013 | 31 Dec 2013 | 9.53 | 66.06B | 6.93B |
| Q3 FY2013 | 30 Sept 2013 | 8.94 | 57.08B | 6.38B |
| Q2 FY2013 | 30 Jun 2013 | 8.71 | 51.74B | 5.94B |
| Q1 FY2013 | 31 Mar 2013 | 8.10 | 45.66B | 5.64B |
| Q4 FY2012 | 31 Dec 2012 | 6.28 | 34.63B | 5.52B |
| Q3 FY2012 | 30 Sept 2012 | 6.54 | 35.46B | 5.43B |
| Q2 FY2012 | 30 Jun 2012 | 6.79 | 34.51B | 5.08B |
| Q1 FY2012 | 31 Mar 2012 | 6.20 | 30.21B | 4.87B |
| Q4 FY2011 | 31 Dec 2011 | 5.59 | 26.74B | 4.78B |
| Q3 FY2011 | 30 Sept 2011 | 4.84 | 22.62B | 4.67B |
| Q2 FY2011 | 30 Jun 2011 | 5.39 | 25.91B | 4.81B |
| Q1 FY2011 | 31 Mar 2011 | 3.69 | 17.75B | 4.81B |
| Q4 FY2010 | 31 Dec 2010 | 3.43 | 16.19B | 4.72B |
| Q3 FY2010 | 30 Sept 2010 | 2.91 | 13.46B | 4.62B |
| Q2 FY2010 | 30 Jun 2010 | 2.70 | 12.33B | 4.57B |
| Q1 FY2010 | 31 Mar 2010 | 3.48 | 15.49B | 4.45B |
| Q4 FY2009 | 31 Dec 2009 | 3.30 | 14.44B | 4.38B |
| Q3 FY2009 | 30 Sept 2009 | 3.38 | 14.60B | 4.32B |
| Q2 FY2009 | 30 Jun 2009 | 3.04 | 13.03B | 4.29B |
| Q1 FY2009 | 31 Mar 2009 | 3.60 | 15.08B | 4.19B |
| Q4 FY2008 | 31 Dec 2008 | 3.34 | 13.70B | 4.10B |
| Q3 FY2008 | 30 Sept 2008 | 3.74 | 14.65B | 3.92B |
| Q2 FY2008 | 30 Jun 2008 | 4.49 | 16.23B | 3.62B |
| Q1 FY2008 | 31 Mar 2008 | 5.38 | 18.27B | 3.40B |
| Q4 FY2007 | 31 Dec 2007 | 5.32 | 16.86B | 3.17B |
| Q3 FY2007 | 30 Sept 2007 | 9.02 | 19.63B | 2.18B |
| Q2 FY2007 | 30 Jun 2007 | 8.71 | 18.21B | 2.09B |
| Q1 FY2007 | 31 Mar 2007 | 7.64 | 15.10B | 1.98B |
| Q4 FY2006 | 31 Dec 2006 | 8.94 | 16.74B | 1.87B |
| Q3 FY2006 | 30 Sept 2006 | 7.95 | 15.10B | 1.90B |
| Q2 FY2006 | 30 Jun 2006 | 8.85 | 15.86B | 1.79B |
| Q1 FY2006 | 31 Mar 2006 | 9.21 | 16.00B | 1.74B |
| Q4 FY2005 | 31 Dec 2005 | 8.97 | 15.38B | 1.71B |
| Q3 FY2005 | 30 Sept 2005 | 7.54 | 13.29B | 1.76B |
| Q2 FY2005 | 30 Jun 2005 | 6.71 | 11.46B | 1.71B |
| Q1 FY2005 | 31 Mar 2005 | 7.05 | 11.57B | 1.64B |
| Q4 FY2004 | 31 Dec 2004 | 13.99 | 22.33B | 1.60B |
| Q3 FY2004 | 30 Sept 2004 | 15.57 | 20.48B | 1.31B |
| Q2 FY2004 | 30 Jun 2004 | 23.42 | 21.32B | 910.09M |
| Q1 FY2004 | 31 Mar 2004 | 37.46 | 18.54B | 494.89M |
| Q4 FY2003 | 31 Dec 2003 | 173.97 | 12.25B | 70.39M |
| Q3 FY2003 | 30 Sept 2003 | 19.04 | 12.98B | 681.77M |
| Q2 FY2003 | 30 Jun 2003 | 15.93 | 13.24B | 831.57M |
| Q1 FY2003 | 31 Mar 2003 | 13.65 | 13.34B | 977.27M |
| Q4 FY2002 | 31 Dec 2002 | 11.26 | 12.94B | 1.15B |
| Q3 FY2002 | 30 Sept 2002 | 14.37 | 16.19B | 1.13B |
| Q2 FY2002 | 30 Jun 2002 | 11.52 | 12.71B | 1.10B |
| Q1 FY2002 | 31 Mar 2002 | 23.35 | 25.56B | 1.09B |
| Q4 FY2001 | 31 Dec 2001 | 25.77 | 26.88B | 1.04B |
| Q3 FY2001 | 30 Sept 2001 | 19.96 | 20.12B | 1.01B |
| Q2 FY2001 | 30 Jun 2001 | 27.03 | 26.40B | 976.72M |
| Q1 FY2001 | 31 Mar 2001 | 16.48 | 15.60B | 946.65M |
| Q4 FY2000 | 31 Dec 2000 | 30.37 | 28.13B | 926.45M |
| Q3 FY2000 | 30 Sept 2000 | 28.65 | 25.97B | 906.45M |
| Q2 FY2000 | 30 Jun 2000 | 19.79 | 17.44B | 881.10M |
| Q1 FY2000 | 31 Mar 2000 | 17.60 | 14.77B | 839.51M |
| Q4 FY1999 | 31 Dec 1999 | 18.60 | 14.77B | 794.38M |
| Q3 FY1999 | 30 Sept 1999 | 19.28 | 14.22B | 737.44M |
| Q2 FY1999 | 30 Jun 1999 | 17.09 | 11.53B | 674.94M |
| Q1 FY1999 | 31 Mar 1999 | 12.32 | 7.57B | 614.81M |
| Q4 FY1998 | 31 Dec 1998 | 12.43 | 6.93B | 557.59M |
| Q3 FY1998 | 30 Sept 1998 | 6.42 | 3.43B | 535.34M |
| Q2 FY1998 | 30 Jun 1998 | 7.19 | 3.52B | 490.04M |
| Q1 FY1998 | 31 Mar 1998 | 14.27 | 6.47B | 453.64M |
| Q4 FY1997 | 31 Dec 1997 | 11.59 | 5.03B | 433.94M |
| Q3 FY1997 | 30 Sept 1997 | 15.62 | 6.13B | 392.59M |
| Q2 FY1997 | 30 Jun 1997 | 8.87 | 3.45B | 388.79M |
| Q1 FY1997 | 31 Mar 1997 | 9.99 | 3.37B | 337.59M |
| Q4 FY1996 | 31 Dec 1996 | 12.14 | 3.36B | 277.19M |
| Q3 FY1996 | 30 Sept 1996 | 15.00 | 3.38B | 225.49M |
| Q2 FY1996 | 30 Jun 1996 | 18.99 | 3.09B | 162.59M |
| Q1 FY1996 | 31 Mar 1996 | 19.51 | 3.01B | 154.09M |
| Q4 FY1995 | 31 Dec 1995 | 15.85 | 2.41B | 151.69M |
| Q3 FY1995 | 30 Sept 1995 | 6.12 | 866.25M | 141.54M |
| Q2 FY1995 | 30 Jun 1995 | 5.04 | 703.13M | 139.44M |
| Q1 FY1995 | 31 Mar 1995 | 3.76 | 525.00M | 139.54M |
| Q4 FY1994 | 31 Dec 1994 | 2.00 | 297.50M | 148.74M |
| Q3 FY1994 | 30 Sept 1994 | 2.22 | 313.50M | 141.00M |
| Q2 FY1994 | 30 Jun 1994 | 2.32 | 331.50M | 143.10M |
| Q1 FY1994 | 31 Mar 1994 | 3.74 | 542.50M | 145.00M |
| Q4 FY1993 | 31 Dec 1993 | 5.91 | 805.00M | 136.30M |
| Q3 FY1993 | 30 Sept 1993 | 4.11 | 627.78M | 152.60M |
| Q2 FY1993 | 30 Jun 1993 | 3.93 | 616.00M | 156.60M |
| Q1 FY1993 | 31 Mar 1993 | 5.80 | 812.19M | 140.00M |
| Q4 FY1992 | 31 Dec 1992 | 10.00 | 1.24B | 123.60M |
| Q3 FY1992 | 30 Sept 1992 | 9.16 | 801.67M | 87.50M |
| Q2 FY1992 | 30 Jun 1992 | 7.20 | 463.75M | 64.40M |
| Q1 FY1992 | 31 Mar 1992 | 14.29 | 880.00M | 61.60M |
| Q4 FY1991 | 31 Dec 1991 | 16.94 | 1.04B | 61.40M |
| Q3 FY1991 | 30 Sept 1991 | 31.35 | 1.88B | 59.80M |
| Q2 FY1991 | 30 Jun 1991 | 35.87 | 2.06B | 57.50M |
| Q1 FY1991 | 31 Mar 1991 | 24.22 | 1.31B | 54.20M |
| Q4 FY1990 | 31 Dec 1990 | 26.20 | 1.31B | 50.10M |
| Q3 FY1990 | 30 Sept 1990 | 27.83 | 1.22B | 43.80M |
| Q2 FY1990 | 30 Jun 1990 | 31.82 | 1.22B | 38.30M |
| Q1 FY1990 | 31 Mar 1990 | 36.71 | 1.22B | 33.20M |
| Q4 FY1989 | 31 Dec 1989 | 41.31 | 1.22B | 29.50M |
| Q3 FY1989 | 30 Sept 1989 | 44.16 | 1.22B | 27.60M |
| Q2 FY1989 | 30 Jun 1989 | 50.36 | 1.22B | 24.20M |
| Q1 FY1989 | 31 Mar 1989 | 32.47 | 750.00M | 23.10M |
| Q4 FY1988 | 31 Dec 1988 | 36.41 | 750.00M | 20.60M |
| Q3 FY1988 | 30 Sept 1988 | 44.64 | 750.00M | 16.80M |
| Q2 FY1988 | 30 Jun 1988 | 112.50 | 1.69B | 15.00M |
| Q1 FY1988 | 31 Mar 1988 | 154.82 | 1.69B | 10.90M |
| Q4 FY1987 | 31 Dec 1987 | 189.43 | 1.61B | 8.50M |
| Q3 FY1987 | 30 Sept 1987 | 218.75 | 1.64B | 7.50M |
| Q2 FY1987 | 30 Jun 1987 | 241.70 | 1.55B | 6.40M |
| Q1 FY1987 | 31 Mar 1987 | 223.88 | 1.50B | 6.70M |
| Q4 FY1986 | 31 Dec 1986 | 238.10 | 1.50B | 6.30M |
| Q3 FY1986 | 30 Sept 1986 | 167.41 | 1.41B | 8.40M |
| Q2 FY1986 | 30 Jun 1986 | 119.30 | 1.40B | 11.70M |
| Q1 FY1986 | 31 Mar 1986 | — | 1.31B | — |
| Q4 FY1985 | 31 Dec 1985 | — | 1.31B | — |
| Q3 FY1985 | 30 Sept 1985 | — | 1.29B | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Biogen's P/S ratio
Source: Financial Modeling Prep